Trial intelligence / Profile preview

Ramipril for Vascular Inflammation in CAD

NCT00005928Phase 2Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Jun 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ramipril in coronary artery disease (CAD), sponsored by National Heart, Lung, and Blood Institute. Started Jun 2000; status: completed.

02

Drugs

ramipril
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT00005928.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005928.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call